SeaCrest Wealth Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-13,782
Closed -$1.02M – 652
2025
Q2
$1.02M Sell
13,782
-2,340
-15% -$163K 0.11% 175
2025
Q1
$1.3M Buy
16,122
+16
+0.1% +$1.38K 0.15% 134
2024
Q4
$1.26M Sell
16,106
-1,067
-6% -$90.7K 0.13% 143
2024
Q3
$1.61M Sell
17,173
-391
-2% -$32.8K 0.17% 112
2024
Q2
$1.37M Buy
17,564
+1,008
+6% +$82.2K 0.16% 125
2024
Q1
$1.51M Sell
16,556
-1,922
-10% -$160K 0.18% 117
2023
Q4
$1.42M Buy
18,478
+2,057
+13% +$144K 0.17% 121
2023
Q3
$1.12M Buy
16,421
+3,743
+30% +$272K 0.15% 145
2023
Q2
$1.03M Buy
12,678
+768
+6% +$61.3K 0.13% 161
2023
Q1
$977K Buy
+11,910
New +$850K 0.13% 172

Other funds holding GEHC

SeaCrest Wealth Management's GEHC Position: Q3 2025 in Review

SeaCrest Wealth Management sold out of GE HealthCare (GEHC) in Q3 2025, closing a stake of 13,782 shares — an estimated $1.02M sold.

SeaCrest Wealth Management first reported a position in GEHC in Q1 2023 and held it in 10 quarters. The position peaked at $1.61M in Q3 2024. 1,281 funds tracked by Wall St. Rank hold GEHC as of Q3 2025.

  • SeaCrest Wealth Management reported no remaining GE HealthCare position as of Q3 2025 after selling out during the quarter.
  • SeaCrest Wealth Management sold 13,782 GE HealthCare shares in Q3 2025, an estimated $1.02M.
  • SeaCrest Wealth Management first reported a position in GE HealthCare in Q1 2023 and held it in 10 quarters.
  • SeaCrest Wealth Management's GE HealthCare position peaked at $1.61M in Q3 2024.
  • 1,281 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2025.

Based on SeaCrest Wealth Management's 13F filing for Q3 2025, filed 13 Nov 2025.